Are G protein-coupled receptor heterodimers of physiological relevance? Focus on melatonin receptors

被引:43
|
作者
Levoye, A
Jockers, R
Ayoub, MA
Delagrange, P
Savaskan, E
Guillaume, JL
机构
[1] Univ Paris 05, Fac Med, Inst Cochin, Dept Cell Biol, F-75014 Paris, France
[2] Univ Montpellier 1, Inst Genom Fonct, Dept Mol Pharmacol, Marseille, France
[3] Univ Montpellier 2, Marseille, France
[4] Inst Rech Servier, F-92150 Suresnes, France
[5] Psychiat Univ Clin, Basel, Switzerland
关键词
melatonin; circadian rhythm; G protein-coupled receptors;
D O I
10.1080/07420520500521863
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In mammals, the circadian hormone melatonin targets two seven- transmembrane spanning receptors, MT1 and MT2, of the G protein-coupled receptor (GPCR) super-family. Evidence accumulated over the last 15 yrs convincingly demonstrates that GPCRs, classically considered to function as monomers, are actually organized as homodimers and heterodimerize with other GPCR family members. These dimers are formed early in the biosynthetic pathway and remain stable throughout the entire life cycle. A growing number of observations demonstrate that GPCR oligomerization may occur in native tissues and may have important consequences on receptor function. The formation of MT1 and MT2 homodimers and MT1/MT2 heterodimers has been shown in heterologous expression systems at physiological expression levels. Formation of MT1/MT2 heterodimers remains to be shown in native tissues but is suggested by the documented co-expression of MT1 and MT2 in many melatonin-sensitive tissues, such as the hypothalamic suprachiasmatic nuclei, retina, arteries, and adipose tissue. Considering that multiple GPCRs are expressed simultaneously in most cells, the possible engagement into heterodimeric complexes has to be considered and taken into account for the interpretation of experimental data obtained from native tissues and knockout animals.
引用
收藏
页码:419 / 426
页数:8
相关论文
共 50 条
  • [31] G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery
    Milligan, Graeme
    DRUG DISCOVERY TODAY, 2006, 11 (11-12) : 541 - 549
  • [32] Downregulation of G protein-coupled receptors
    Tsao, P
    von Zastrow, M
    CURRENT OPINION IN NEUROBIOLOGY, 2000, 10 (03) : 365 - 369
  • [33] G protein-coupled receptors in silico
    Florence Horn
    Gerrit Vriend
    Journal of Molecular Medicine, 1998, 76 : 464 - 468
  • [34] G protein-coupled receptors in rheumatology
    Elena Neumann
    Kiran Khawaja
    Ulf Müller-Ladner
    Nature Reviews Rheumatology, 2014, 10 : 429 - 436
  • [35] G protein-coupled receptors and obesity
    Pocai, Alessandro
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [36] Desensitization of G protein-coupled receptors
    Freedman, NJ
    Lefkowitz, RJ
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 51: PROCEEDINGS OF THE 1995 CONFERENCE, 1996, 51 : 319 - 353
  • [37] G protein-coupled receptors in silico
    Horn, F
    Vriend, G
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (07): : 464 - 468
  • [38] G Protein-Coupled Receptors in Macrophages
    Lin, Hsi-Hsien
    Stacey, Martin
    MICROBIOLOGY SPECTRUM, 2016, 4 (04):
  • [39] THE STRUCTURE OF G PROTEIN-COUPLED RECEPTORS
    BALDWIN, JM
    BIOPHYSICAL JOURNAL, 1994, 66 (02) : A139 - A139
  • [40] Lysophospholipid G protein-coupled receptors
    Anliker, B
    Chun, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (20) : 20555 - 20558